wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35781556-8AF26D83-94C1-4091-B647-502C9DA2F0B3
Q35781556-8AF26D83-94C1-4091-B647-502C9DA2F0B3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35781556-8AF26D83-94C1-4091-B647-502C9DA2F0B3
Prognostic factors of survival in patients treated with nab-paclitaxel plus gemcitabine regimen for advanced or metastatic pancreatic cancer: a single institutional experience
P2860
Q35781556-8AF26D83-94C1-4091-B647-502C9DA2F0B3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35781556-8AF26D83-94C1-4091-B647-502C9DA2F0B3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8f86cb0a0fc470ac4ce815b9da0698afe161d675
P2860
Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer.